Investigational Site Number 376002

Kfar Saba 44281

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Squamous Cell Lung Cancer

Studies at this site

• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
• Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) — Completed